Aligos Therapeutics 

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$9.62
Previous Close
$9.48
Day Range
$9.51-$9.73
52W Range
$6.76-$30
Market Cap
$30.5M
Shares Short
82,817

Financials

See more
Revenue (12 Mos)
$7.9M
Revenue Growth (YoY)
-84.6%
Gross Profit (12 Mos)
-$71.1M
Diluted EPS
-$14.50

News

See more

Yahoo Finance • 11 months ago

13 Stocks Insiders are Buying Now

Yahoo Finance • 12 months ago

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile

Yahoo Finance • 12 months ago

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

Yahoo Finance • 12 months ago

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule, and Updates on Several Preclinical Candidates for the Treatment of Chronic Hepatitis B, in Addition to the Recently Announced Late Breaker Poster (#5028-C)

About

CEO
Dr. Lawrence M. Blatt MBA, Ph.D.
CFO
Ms. Lesley Ann Calhoun CPA
Address
One Corporate Drive, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
68